A preview of the upcoming 30th International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2019), which is due to be held on 15–18 September 2019 at the Convention Centre of The Dan Panorama Hotel in Tel Aviv, Israel.
allegro60/stock.adobe.com
A preview of the upcoming 30th International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2019), which is due to be held on 15–18 September 2019 at the Convention Centre of The Dan Panorama Hotel in Tel Aviv, Israel.
The organizing committee invites you to attend the 30th International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2019), which will be held 15–18 September 2019 at the Convention Centre of The Dan Panorama hotel in Tel Aviv, Israel.
It follows a series of successful PBA symposia organized all over the world since 1987, when the first International Symposium on Pharmaceutical and Biomedical Analysis (PBA) was launched in Barcelona, Spain. Now, for the first time in its history, the symposium arrives in the Middle East.
The symposium will cover all aspects of pharmaceutical and biomedical analysis, including new analytical technologies and methodologies for (bio)pharmaceuticals, biomarkers, and “omics”. A special session will be focused on the emerging field of medical cannabis. It is in the spirit of this symposium series to attract researchers from all over the world, from a broad range of areas involved in drug analysis, related materials, and endogenous compounds.
Plenary and keynote lectures will be given by internationally recognized invited speakers. A number of materials will be presented as oral communications and poster presentations. Participation of young researchers, both from industry and academia, will be strongly supported by a dedicated young scientist session, best oral presentation, and poster awards, as well as a reduced registration fee and affordable lodging.
Photo credit: Bioforum
PBA 2019 will also offer stimulating and highly informative workshops by recognized experts in their field; these will be run in parallel on Sunday 15 September from 9:00 to 13:00. These workshops include:
Participants are also invited to submit manuscripts based on presentations at the PBA 2019 meeting for possible publication in the Journal of Pharmaceutical and Biomedical Analysis (JPBA), with the intention of publishing a special issue dedicated to the meeting. Such special issue publications essentially rule out possible delays for contributors.
One of the major aims of the symposium is to provide a forum for highâlevel scientific exchange between analytically oriented scientists from the whole world in a friendly atmosphere.
Tel Aviv, with its special cosmopolitan atmosphere, can offer excellent opportunities for scientific, cultural, and social experiences in a unique Mediterranean seaside setting. The symposium venue is located within walking distance from Old Jaffa. This ancient city with more than 3000 years’ history is in the oldest part of Tel Aviv, and is famous for its association with the biblical stories of Jonah, Solomon, and Saint Peter, as well as the mythological story of Andromeda and Perseus.
An attractive programme of social events will also be arranged during the symposium, including a full-day guided tour to Jerusalem on 19 September.
As a country geographically bridging Europe, Asia, and Africa and located on the crossroads of culture and religion, Israel enjoys the established status as one of the most popular tourist destinations.
The organizers look forward to seeing you in September 2019 and wish you a fruitful and enjoyable stay in Israel.
More details on the topics, invited speakers, registration, abstract submission, conference fees, and important dates can be found on the conference website: www.pba2019.org.
Vladimir Ioffe
PBA-2019 Chairmanvladimir.ioffe@teva.co.il
E-mail:bioforum@bioforum.co.il Website: www.pba2019.org
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.